269 related articles for article (PubMed ID: 12806561)
1. Ovarian cancer and fertility medications: a critical appraisal.
Kashyap S; Davis OK
Semin Reprod Med; 2003 Feb; 21(1):65-71. PubMed ID: 12806561
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
3. The risk of ovarian cancer after treatment for infertility.
Bristow RE; Karlan BY
Curr Opin Obstet Gynecol; 1996 Feb; 8(1):32-7. PubMed ID: 8777256
[TBL] [Abstract][Full Text] [Related]
4. [Three cases of ovarian cancer after ovulation induction for infertility].
Abboud J; Attieh E; Atallah D; Kessrouani A; Chaoul G
Contracept Fertil Sex; 1997 Jan; 25(1):64-5. PubMed ID: 9064055
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer associated with ovulation induction: a case report.
Adewole IF; Babarinsa IA; Thomas JO; Ajayi AB
Afr J Med Med Sci; 1997; 26(3-4):203-4. PubMed ID: 10456173
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovulation and ovarian cancer: a critical review of the literature.
Mahdavi A; Pejovic T; Nezhat F
Fertil Steril; 2006 Apr; 85(4):819-26. PubMed ID: 16580355
[TBL] [Abstract][Full Text] [Related]
7. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.
Ayhan A; Salman MC; Celik H; Dursun P; Ozyuncu O; Gultekin M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1104-11. PubMed ID: 15548140
[TBL] [Abstract][Full Text] [Related]
8. Infertility and ovarian cancer.
Chatterjee SK
J Indian Med Assoc; 1999 Feb; 97(2):69. PubMed ID: 10549200
[No Abstract] [Full Text] [Related]
9. Assisted reproductive technology and ovarian cancer.
Devesa M; Barri PN; Coroleu B
Minerva Endocrinol; 2010 Dec; 35(4):247-57. PubMed ID: 21178919
[TBL] [Abstract][Full Text] [Related]
10. Ovulation induction and ovarian malignancy.
Beltsos AN; Odem RR
Semin Reprod Endocrinol; 1996 Nov; 14(4):367-74. PubMed ID: 8988531
[TBL] [Abstract][Full Text] [Related]
11. Fertility drugs and risk of ovarian cancer: dispelling the myth.
Zreik TG; Ayoub CM; Hannoun A; Karam CJ; Munkarah AR
Curr Opin Obstet Gynecol; 2008 Jun; 20(3):313-9. PubMed ID: 18460948
[TBL] [Abstract][Full Text] [Related]
12. Treatment for fertility and risk of ovarian tumors of borderline malignancy.
Parazzini F; Negri E; La Vecchia C; Moroni S; Polatti A; Chiaffarino F; Surace M; Ricci E
Gynecol Oncol; 1998 Mar; 68(3):226-8. PubMed ID: 9570970
[TBL] [Abstract][Full Text] [Related]
13. Fertility therapy in the setting of a history of invasive epithelial ovarian cancer.
Bandera CA; Cramer DW; Friedman AJ; Sheets EE
Gynecol Oncol; 1995 Jul; 58(1):116-9. PubMed ID: 7789877
[TBL] [Abstract][Full Text] [Related]
14. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
[TBL] [Abstract][Full Text] [Related]
15. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
16. Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations.
Saylam K; Devreker F; Simon P; Fayt I; Noël JC
Acta Obstet Gynecol Scand; 2006; 85(12):1506-7. PubMed ID: 17260230
[No Abstract] [Full Text] [Related]
17. Infertility as a cancer risk factor - a review.
Cetin I; Cozzi V; Antonazzo P
Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
[TBL] [Abstract][Full Text] [Related]
18. In vitro fertilization and breast cancer risk: a review.
Salhab M; Al Sarakbi W; Mokbel K
Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
[TBL] [Abstract][Full Text] [Related]
19. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
Gadducci A; Guerrieri ME; Genazzani AR
Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
[TBL] [Abstract][Full Text] [Related]
20. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
